Targeted drugs in small-cell lung cancer - Wikidata - wikimedia - TriplyDB

Targeted drugs in small-cell lung cancer

Targeted drugs in small-cell lung cancer

http://www.wikidata.org/entity/Q26767017

about

LF-MF inhibits iron metabolism and suppresses lung cancer through activation of P53-miR-34a-E2F1/E2F3 pathway.Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance.Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy miR-21 modulates the effect of EZH2 on the biological behavior of human lung cancer stem cells in vitro.Targeting chaperonin containing TCP1 (CCT) as a molecular therapeutic for small cell lung cancer.A recurrence-free survivor with chemotherapy-refractory small cell lung cancer after pneumonectomy: A case report and review of the literature.Sodium Valproate Inhibits Small Cell Lung Cancer Tumor Growth on the Chicken Embryo Chorioallantoic Membrane and Reduces the p53 and EZH2 Expression.Advanced small cell lung cancer (SCLC): new challenges and new expectations.

P2860

Q33677983-543DABD7-8A1A-4F15-9C7B-9D130A17F862 Q41009718-F421E98B-E911-4FF8-BA31-84ADF60BE7CC Q41472275-4DC06647-1C37-4434-9143-26E35DA3F67E Q47093759-E7AC1623-6DBC-4240-9629-25A5DB196C15 Q47107751-ED0E5E9D-179A-45B3-9374-B680C3EB0C11 Q47141710-2629005E-A16E-491E-AF90-AE626AD8E8E7 Q54118413-95B44E72-D003-4A2A-ACD3-46D4AC2853B3 Q54977232-444C3B1C-13F8-4D71-AABE-D494CFC4EBDF

P2860

Targeted drugs in small-cell lung cancer

http://www.wikidata.org/entity/Q26767017

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Targeted drugs in small-cell lung cancer

@ast

Targeted drugs in small-cell lung cancer

@en

Targeted drugs in small-cell lung cancer

@nl

type

label

Targeted drugs in small-cell lung cancer

@ast

Targeted drugs in small-cell lung cancer

@en

Targeted drugs in small-cell lung cancer

@nl

prefLabel

Targeted drugs in small-cell lung cancer

@ast

Targeted drugs in small-cell lung cancer

@en

Targeted drugs in small-cell lung cancer

@nl

P1433

Q26767017-E8648C1F-599C-49AE-A24E-FC05BFD87A0E

P1476

Q26767017-DD6D65AE-DB19-44DC-B326-3C8564DBFD04

P2093

Q26767017-3529D439-8814-4BD5-A609-E22D983984A3

Q26767017-4BB51BC6-CE8A-40F5-A52E-E7870F40671A

Q26767017-4E1F388F-C12A-48CB-86C9-07BEA23A2817

Q26767017-54CE0E17-9A9B-4B07-945A-517E6424A156

Q26767017-7CB92B55-E0F3-416F-9FF4-957D37740B05

Q26767017-A94BF0F6-2025-45E3-92BC-CD7DF0544BA3

P2860

Q26767017-00CE687C-DD71-4B33-8DFB-145C8520D139

Q26767017-02B4B039-F92B-46E6-B595-FBE9B3C7E0CC

Q26767017-02B530AA-914D-4FF4-9573-C163298AB623

Q26767017-098B9D1E-0715-4AA9-968E-D1FB0886A4F4

Q26767017-0AFB5B4E-B322-47EF-93AC-4357DDB396A2

Q26767017-0BA4BA55-1ED4-446D-B4B6-C55B0643FAC4

Q26767017-0BA6483D-C66F-4E15-811D-53638AA589F0

Q26767017-0D5A2202-A65D-4181-99A7-ACB4299D3C3D

Q26767017-10F9378D-4248-484C-B8D3-0075E32A6E0D

Q26767017-12686A6B-2F64-4CE4-8861-CAFECF71D7DB

P304

Q26767017-2F224270-73AC-4272-BB29-27AC26B0B006

P31

Q26767017-37E6BE1A-47D9-47F7-84F8-EE7E9F174B65

P356

Q26767017-69ADA215-D8EA-44CC-AEF7-96FFAEEFE378

P407

Q26767017-5232E61A-88B4-415E-837E-1204C16AFB19

P433

Q26767017-C5F5F04A-8E42-4E65-91B7-93781B7BD36F

P478

Q26767017-547E35FB-1897-4B31-88E0-B99955638D15

P50

Q26767017-9D930757-F8F6-42C1-B5DF-A00A1E9A6BCE

P577

Q26767017-89DA68F3-A0BA-49D9-89A7-542DCB7B99BF

P698

Q26767017-06EC4B16-4CF1-4285-950A-D961D11A7C66

P932

Q26767017-EAF437EF-30C7-4B18-BD19-1631976DA292

P356

J.ISSN.2218-6751.2016.01.12

P1433

Translational lung cancer research

P1476

Targeted drugs in small-cell lung cancer

@en

P2093

Chiara Lazzari

http://www.w3.org/2001/XMLSchema#string

Giuseppe Altavilla

http://www.w3.org/2001/XMLSchema#string

Maria González-Cao

http://www.w3.org/2001/XMLSchema#string

Maria Grazia Daffinà

http://www.w3.org/2001/XMLSchema#string

Mariacarmela Santarpia

http://www.w3.org/2001/XMLSchema#string

Niki Karachaliou

http://www.w3.org/2001/XMLSchema#string

P2860

PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase

A small-cell lung cancer genome with complex signatures of tobacco exposure

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501

Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta role

Advances in immunotherapy for treatment of lung cancer

Origins, genetic landscape, and emerging therapies of small cell lung cancer

Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy

P304

51-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2218-6751.2016.01.12

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26958493

http://www.w3.org/2001/XMLSchema#string

P932

4758978

http://www.w3.org/2001/XMLSchema#string